Your session is about to expire
← Back to Search
Oxytocin for Patient-Reported Outcome Measures (PROMs) (POM PROM Trial)
POM PROM Trial Summary
This trial is testing whether oxytocin or oral misoprostol results in a shorter interval to delivery after the start of induction among nulliparous women with unfavorable cervical exams and term premature rupture of membranes.
- Patient-Reported Outcome Measures (PROMs)
POM PROM Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPOM PROM Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.POM PROM Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What conditions is Oxytocin generally prescribed to ameliorate?
"Oxytocin can be administered to address the effects of nsaid use, labour, and uterine contractions."
What is the scope of enrollment for this clinical investigation?
"Yes, the information on clinicaltrials.gov attests that this medical trial is actively recruiting patients. This project was first made public on August 12th 2019 and has been recently updated on July 18th 2022. 155 participants need to be enlisted from one location for enrollment purposes."
Has the FDA sanctioned Oxytocin for medical use?
"We have assigned a score of 3 for Oxytocin's safety due to the fact that this is already an approved treatment, as evidenced by its Phase 4 trial status."
Does this trial have any openings for participants at the moment?
"Affirmative. The chronology listed on clinicaltrials.gov shows that this medical trial was first posted on August 12th 2019 and is currently seeking participants, with the most recent edit being made July 18th 2022. 155 patients must be recruited from a single site for the study to continue apace."
Share this study with friends
Copy Link
Messenger